Riskpilot← Back to searchSign inGet full accessOPTINOSE AS
ASActiveOrg 982483131Gaustadalléen 21, 0349 OsloManufacture of medical and dental instruments and supplies · NACE 3250Est. 20000 employeeswww.optinose.no
Revenue 2022
NOK 51,6M
+4847% vs 2021
EBITDA margin
96.2%
+1661% vs 2021
Equity ratio
100.0%
Financial strength
Net profit 2022
NOK 49,4M
+1501% vs 2021
| Revenue | NOK 51,6M | +4847% |
| EBITDA | NOK 49,6M | +1661% |
| Net profit | NOK 49,4M | +1501% |
| Total assets | NOK 45,8M | +1938% |
| Equity | NOK 45,8M | +1362% |
| Employees | 0 | — |
Legal name
OPTINOSE AS
Org number
982483131
Legal form
Aksjeselskap
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
13. oktober 2000
Share capital
NOK 28 088 621 440
Employees
0
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Utvikling, administrasjon, kommersialisering og distribusjon av legemiddelfordelingsinnretninger, herunder, men ikke begrenset til nasal- og oralinnretninger basert på et patentert prinsipp (patentsøknad ipa no pct/ib 00/00273 "nasal delivery divice"). Formålet omfatter også produkter, tjenester og andre tilbud knyttet til patentet i tillegg til immaterielle rettigheter og patenter som er utviklet eller på annen måte ervervet av selskapet, herunder produksjon, administrasjon og distribusjon av produkter som er avledet fra teknologi som er basert på lignende patenterte prinsipper og andre immaterielle rettigheter eller patenter som selskapet til enhver tid har utviklet, lisensiert eller på annet måte ervervet.
Address
Gaustadalléen 21, 0349 Oslo
Website
www.optinose.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Revenue | 50 398 | 4 799 | 1 056 | 1 043 | 51 600 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 46 046 | −290 | −4 739 | −3 180 | 49 650 |
| Depreciation & amort. | −1 | −1 | −2 | −0 | −0 |
| EBIT | 46 045 | −291 | −4 741 | −3 180 | 49 650 |
| Net financials | −6 298 | −6 585 | −1 137 | −349 | −203 |
| Profit before tax | 39 747 | −6 876 | −5 878 | −3 529 | 49 447 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 39 747 | −6 876 | −5 878 | −3 529 | 49 447 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Total assets | 45 713 | 5 111 | 3 743 | 2 249 | 45 838 |
| Equity | −10 807 | −17 683 | −102 | −3 632 | 45 838 |
| Long-term debt | 48 794 | 0 | 0 | 0 | 0 |
| Short-term debt | 7 726 | 22 794 | 3 845 | 5 881 | 0 |
| Total debt | 56 520 | 22 794 | 3 845 | 5 881 | 0 |
EBITDA margin
96.2%
This company
15.8%
Market median
+509% vs market
20182022
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20182022
Return on equity
107.9%
This company
18.4%
Market median
+486% vs market
20182022
Net profit margin
95.8%
This company
8.1%
Market median
+1083% vs market
20182022
Asset turnover
1.13×
This company
1.12×
Market median
+1% vs market
20182022
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20182022
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Chairman | 2018 | |
| Board of Directors | 2018 | |
| Board of Directors | 2018 | |
| Board of Directors | 2018 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of OPTINOSE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Peter Kaighn Miller | Chairman | 0 companies |
| Per Gisle Djupesland | Board of Directors | 0 companies |
| Helena Kyttari Djupesland | Board of Directors | 0 companies |
| Michael Francis Marino Iii | Board of Directors | 0 companies |